Atlas Trials

NSCLC (Non-small Cell Lung Cancer)

66 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch NSCLC (Non-small Cell Lung Cancer)

RecordFirmDate
IBI310 (Anti-CTLA-4) in Combination With Sintilimab in Patients With Non-small-cell Lung Cancer (NSCLC) (NCT05118334)Innovent Biologics (Suzhou) Co. Ltd.2021-11-12
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) (NCT04585750)PMV Pharmaceuticals, Inc2020-10-29
Study to Evaluate Concordance of Detecting EGFR (Epidermal Growth Factor Receptor) Mutation by Circulating Tumour Free DNA Versus Tissues Biopsy in NSCLC (Non-small Cell Lung Cancer). (NCT03562819)AstraZeneca2018-08-16
A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma (NCT03207867)Novartis Pharmaceuticals2017-08-28
Anti-PD-L1 in Stage IIIA(N2) Non-small Cell Lung Cancer (NSCLC) (NCT02572843)Swiss Cancer Institute2016-06-16
An Open-label Phase Ib/II Study of BAY 1000394 (Roniciclib) in Combination With Docetaxel in Second- or Third-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC) (NCT02522910)Yonsei University2015-08-01
Gene Molecular Alterations as Disease Prognostic Markers in Patients With Non-small Cell Lung Cancer (NSCLC) (NCT06876402)Hellenic Cooperative Oncology Group2013-09-09
A Study Of Crizotinib Versus Chemotherapy In Previously Untreated ALK Positive East Asian Non-Small Cell Lung Cancer Patients (NCT01639001)Pfizer2012-09-29

Track NSCLC (Non-small Cell Lung Cancer) automatically

Every clearance here is in the API, with alerts when new ones post.